X4 Gets First Approval In Ultra-Rare Disorder, Needs Time To Build A Market

 
• By Joseph Haas
  
FDA Approved
X4 gets its first drug approval, in ultra-rare WHIM syndrome
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip